DEBx Medical and DEBRICHEM featured on Bioworld MedTech

Last Friday, a new article about DEBx Medical and our product DEBRICHEM was published online on Bioworld Medtech. The article states, among other things, that we have advanced to the pre-launch phase for our new topical desiccant gel for the treatment of chronic infected and necrotic wounds. Two months after obtaining CE mark approval for DEBRICHEM, we are now starting distribution of our class IIb medical device in Europe – in the Netherlands, Italy and Spain – as well as in Hong Kong, South Africa, New Zealand and Australia. 

Curious about what else the journalist had to say about our company and product?

Click here to get access to the full article.

More Posts

In Depth: Biofilms

Virtually all wounds contain bacteria but the type and number of bacteria, their phenotype, as well as the way they are organized determine to what

DEBx Medical Opens Office in US

Exiting things are happening at DEBx Medical, and we want to share some important news with you. We are proud to announce that, despite the

Get in touch


Login to get access to our case reports.


Login to your account